ROADS CLINICAL STUDY for PATIENTS WITH NEWLY DIAGNOSED METASTATIC BRAIN TUMORS | REFER A PATIENT

Radiation Treatments

A CLOSER LOOK AT

Stereotactic Radiotherapy (SRT)

SRT is a precise form of external beam radiation therapy or EBRT (eg, GammaKnife, CyberKnife). During SRT treatment, patients are fitted with a mask that keeps their head perfectly still as a high dose of radiation is delivered to the tumor site.1 SRT is targeted directly at the brain tumor to limit radiation exposure to healthy tissue.1 It is typically completed on an outpatient basis in 1 to 5 treatments.1

A CLOSER LOOK AT

GammaTile® (STaRT)

GammaTile is an implanted Surgically Targeted Radiation Therapy also know as STaRT.2 About the size of a postage stamp, the bioresorbable GammaTile is embedded with 4 small radiation sources. Placed in the last few minutes of brain surgery, the GammaTiles immediately begin delivering targeted radiation to the area where the tumor was removed, limiting radiation exposure to healthy tissue. Over time, and after the therapeutic dose of radiation has been delivered, the body naturally resorbs the collagen GammaTiles. No follow-up surgery for removal is needed.

References:

  1. RT Answers Web site. https://rtanswers.org/How-does-radiation-therapy-work/Stereotactic-Radiation-Therapy. Accessed May 3, 2021.
  2. Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: Safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35-S36

The ROADS Study is sponsored by GT Medical Technologies, Inc., the makers of GammaTile. Please discuss the risks and benefits of participating in this clinical study with your care team.

Indications

GammaTile is indicated to deliver radiation therapy in patients with newly diagnosed malignant and recurrent brain tumors. Possible complications can occur with any neurosurgical procedure and include cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation. For full product and safety information, speak to your physician and refer to the instructions for use.

ROADS CLINICAL STUDY for PATIENTS WITH NEWLY DIAGNOSED METASTATIC BRAIN TUMORS

ENROLLING NOW

©2022 GT Medical Technologies, Inc. I All rights reserved I GammaTile is a registered trademark of GT Medical Technologies, Inc.